Dr Mike Strange joined LifeArc as consultant in May 2022 and took on the role of Head of Global Health in April 2023. Mike oversees our three Global Health Translational Challenges in: Antimicrobial Resistance, Neglected Tropical Diseases and Emerging Viral Threats.
These challenges aim to reduce the burden of infectious diseases by enabling the translation of scientific innovations, accelerating their path to deployment in underserved populations.
Mike previously spent more than 20 years at GlaxoSmithKline (GSK), where he held several senior strategic and operational roles in pharmaceutical and vaccine R&D. For the last 12 years at GSK, he worked in Global Health, where he led the creation of several industry-leading collaborative initiatives including the Tres Cantos Open Lab, the Africa Non-Communicable Diseases Open Lab, and a collaboration with Novartis exploring genetic diversity and response to medicines in African patients.
Mike’s most recent role at GSK was Vice President Global Health Catalyst, where he was responsible for partnerships/external funding, business strategy and operations, and product strategy/market access within GSK’s Global Health Pharma Unit.
Mike has a PhD in Applied Mathematics, an MSc in Mathematics and Biology, a BSc in Mathematics, as well as an Executive MBA from London Business School.
